Anna Marseglia

Anna Marseglia

Assistant Professor

Specialized in vascular contribution to cognitive disorders, cognitive resilience, and sex differences using large multimodal aging cohorts.

Visiting address: Blickagången 16, 14152 Huddinge
Postal address: H1 Neurobiologi, vårdvetenskap och samhälle, H1 Klinisk geriatrik Westman, 171 77 Stockholm

About me

  • I am an Assistant Professor of aging epidemiology and brain health in the Division of Clinical Geriatrics at the Department of Neurobiology, Care Sciences and Society (NVS) at Karolinska Institutet. I have a background in neuropsychology and hold a PhD in aging epidemiology from the Aging Research Center (NVS, KI). Following my PhD, I joined the Westman neuroimaging group in the Division of Clinical Geriatrics for my postdoctoral training and developed an international research profile through national and global collaborations. As part of this, I completed a research exchange at Mayo Clinic Rochester, Minnesota (USA), where I hold a Research Collaborator position. I am also affiliated with the Institute of Neuroscience and Physiology at the Sahlgrenska Academy, University of Gothenburg. I am currectly Vice-Chair of the International Society of Vascular Behavioural and Cognitive Disorders (VasCog) and, since January 2026, I have served as Deputy Section Editor for Epidemiology at Alzheimer’s & Dementia, a leading journal in the field of Alzheimer’s disease and related dementias as well as brain health.


    I welcome inquiries from master's/PhD students and postdocs interested in research internships, exchanges, or thesis projects.

Research

  • My research focuses on understanding vascular contributions to cognitive disorders, particularly linked to cerebral small vessel disease, as well as mechanisms of cognitive resilience. I use multidimensional data from large population‑ and clinical‑based cohorts such as the Gothenburg H70–85 Birth Cohort Studies, the UK Biobank, the Mayo Clinic Study of Aging, and the Rush Alzheimer’s Disease Center cohorts. By integrating clinical, epidemiological, neuroimaging, molecular, and cognitive perspectives, my work aims to clarify mechanisms underlying vulnerability and resilience in cognitive disorders.


    1) Mechanisms of Vascular Cognitive Impairment and Dementia (VCID)
    My team investigates how vascular risk factors and cerebrovascular pathology affect cognitive and brain health. We focus on identifying neuroimaging and molecular biomarkers—particularly those related to inflammation and metabolic dysregulation—that contribute to small vessel disease and shape clinical transitions across the VCID spectrum, including interactions with Alzheimer’s disease co‑pathology.


    2) Determinants of cognitive resilience mechanisms in aging
    We study how life‑course exposures (e.g., education, lifestyle factors, social health) influence cognitive trajectories and the biological systems that support resilience. Using biological measures of cognitive resilience derived from AI‑based neuroimaging metrics such as the Brain Age Gap (a type of "brain clock"), we examine how lifestyle, cerebrovascular and neurodegenerative processes, and inflammatory pathways contribute to preserved cognitive function in aging.


    3) Sex-related differences in VCID and resilience
    We explore biological and sociocultural mechanisms driving sex differences in vulnerability and resilience, including hormonal factors, social determinants, and compensatory pathways. These projects aim to improve understanding of sex‑specific risks and protective mechanisms in VCID.

    Across all research lines, I collaborate closely with national and international partners in brain health research—including colleagues within the VasCog community. These collaborations support cross‑cohort analyses, methodological innovation, and the translation of findings to improve early detection, prevention, and characterization of (vascular) cognitive disorders.

Teaching

  • I teach regularly at both undergraduate and graduate levels in neuroscience, occupational therapy, medicine, and epidemiology at Karolinska Institutet and collaborating institutions. My teaching covers cognitive aging, neuroanatomy, cognitive diagnostics, and epidemiological and statistical methods, integrating biological, clinical, and methodological perspectives across geriatric medicine, public health, and neuroscience.
    I am the coordinator of the KI doctoral course “Cognitive Aging, Neuropsychology and Cognitive Diagnostics” and contribute actively to educational activities within NVS and the Center for Alzheimer Research (CAR; national hub for reserachers in Alzheimer's and other related dementias), where I coordinate the morning coffee seminars and organize scientific workshops featuring international speakers, often in collaboration with StratNeuro, SFOepi, and the KI South Distinguished Lecture Group. I regularly participate in doctoral supervision and leadership training at KI and within the Stockholm Trio to continuously develop my pedagogical skills and sustainable academic leadership.

    I supervise master’s and PhD students as well as guest researchers from diverse backgrounds, mentor early‑career researchers, and serve as examiner for master’s and PhD theses at KI and internationally. I also support academic development as a reviewer for international funding bodies, conferences, and scientific journals, contributing to high‑quality research training and evaluation in the field.

Articles

All other publications

Grants

  • Swedish Research Council
    1 January 2026 - 31 December 2029
    Vascular Cognitive Impairment (VCI) due to cerebrovascular disease—dementia leading cause—is underdiagnosed and poorly understood due to lack of diagnostic criteria and fragmented mechanistic insights. I will uncover health behaviours and biological processes linking inflammation, glucose and lipid metabolism to small vessel disease (SVD) and VCI. My team will: Characterize the natural history of VCI, implementing new diagnostic criteria to identify key transition driversDefine mechanistic pathways linking inflammation and metabolism to SVD and VCI (biosignatures)Determine how a multimodal lifestyle intervention preserves cognition (resilience) despite SVD by modifying transition drivers, biosignatures, or bothBy the project’s end, I will identify biomarkers for early VCI detection and actionable targets for tailored interventions. This will refine risk assessment tools and inform clinical trials and healthcare strategies for effective, person-cantered VCI prevention.We will integrate neuroimaging, clinical, sociobehavioral, and proteomic data—alongside an AI-based resilience measure, the Brain Age Gap—from the H70 and UK Biobank cohorts and the FINGER trial. Using modern statistical methods (eg mixed-effect, multi-state models, random forests), we will achieve our goal within 4 yrs (Yr-1 Aim1
    Yr-2 Aim2
    Yr-3&4 Aim3). My multidisciplinary team (epidemiology, neuroimaging, geriatrics, statistics) and established resources at NVS,KI provide a strong foundation for success.
  • VCI-ADSEX: How does Vascular Pathology Drive Cognitive Impairment? Lifelong determinants, Sex Differences, and Amyloid Co-Pathology
    Alzheimerfonden
    1 January 2026 - 31 December 2026
  • Sex differences in the link between cardiometabolic health, resilience, and cognition.
    Demensförbundet
    1 January 2026 - 31 December 2026
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2025 - 31 December 2027
    Research problem and specific questions Dementia poses a major public health challenge with no cure, underscoring the need for prevention by tackling risk/protective factors like social health (SH
    the ability to engage meaningfully, maintain supportive relationships, and feel belonging within one´s community). Yet, studies often lacked a comprehensive SH framework bridging social and biological dimensions in linking SH and cognitive health and overlooked sex differences. Our project goal is to determine how SH influences cognition leveraging resilience mechanisms across the lifespan, considering factors related to women´s health and sociocultural aspects. This goal will be achieved through 3 research lines (RL) built on a novel conceptual framework from the European SHARED consortium, supported by FORTE. RL1 will investigate the impact of SH, from mid- to late-life, on cognition before dementia manifests, the role of multimorbid disorders and stress. RL2 will investigate how SH contributes to preserving brain integrity (brain maintenance, BM) and/or cognition amid neuropathological changes (cognitive reserve, CR). RL3 will investigate the role of sex differences in the SH-resilience relationship, focusing on sex-specific biological (e.g., hormones-related) and socio-cultural determinants.Data and method We will integrate longitudinal sociobehavioural data with clinical, brain imaging, and women’s health data from the Swedish Betula project (n=4,425, 53% women
    age 25-95 yrs
    25-yr follow-up). We will validate our results externally using the UK Biobank (n=~500,000, 54% women
    age 40-69 yrs
    10-yr follow-up). We will generate biological measures of BM and CR using our in-house artificial intelligence algorithm enable to predict the age of the brain from neuroimaging. Plan for project realisation This 3-year project will be conducted by a research team, which brings together expertise in geriatric epidemiology, psychology, medical sociology, neuroscience, and engineering. Design and methodological aspects are discussed in details in the next sections. We plan to disseminate our findings also outside the scientific community by engaging with local and national end-users. Relevance Our findings will assist clinicians/public health professionals in crafting tailored risk reduction strategies/interventions against dementia for both women and men. Targeting specific SH aspects can enhance cognition before dementia symptoms manifest, across relevant life periods.

Employments

  • Assistant Professor, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 2024-2030
  • Postdoctoral researcher, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 2020-2024

Degrees and Education

  • Degree Of Doctor Of Philosophy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 2018
  • Master's degree in Clinical Psychology, University of Padua, 2009
  • Bachelor's degree in Psychology, University of Padua, 2007

News from KI

Events from KI